Login / Signup

Target trial emulation to assess real-world efficacy in the ESME metastatic breast cancer cohort.

Alison AntoineDavid PérolMathieu RobainSuzette DelalogeChristine LassetYouenn Drouet
Published in: Journal of the National Cancer Institute (2023)
clinicaltrials.gov Identifier NCT03275311.
Keyphrases
  • metastatic breast cancer
  • phase iii
  • study protocol
  • phase ii
  • clinical trial
  • randomized controlled trial
  • open label
  • double blind